Allen Cheng, MD, Erin M. Schumer, MD, MPH, Jaimin R

Slides:

Advertisements

Similar presentations

Changes in Risk Profile Over Time in the Population of a Pediatric Heart Transplant Program Olaf Reinhartz, MD, Katsuhide Maeda, MD, Bruce A. Reitz, MD,

Advertisements

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.

What Predicts Long-Term Survival After Heart Transplantation

Pulmonary Lobectomy in a Patient With a Left Ventricular Assist Device

Benny Weksler, MD, Jennifer L. Sullivan, MD

Adam N. Protos, MD, Jaimin R. Trivedi, MD, MPH, William M

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant Jaimin R. Trivedi, MD,

Outcomes of Reintervention on the Autograft After Ross Procedure

Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M

Berlin Heart EXCOR Ventricular Assist Device: Multilayer Membrane Rupture in a Pediatric Patient Arianna Di Molfetta, PhD, Sergio Filippelli, PhD, Gianfranco.

Preoperative Aspirin Use and Its Effect on Adverse Events in Patients Undergoing Cardiac Operations Jiapeng Huang, MD, PhD, Macarius Donneyong, PhD,

Laura Harvey, MD, Christopher Holley, MD, Samit S

Erin M. Schumer, MD, MPH, Matthew C

Dhaval Chauhan, MD, Alexis K

ABO-Identical Blood Group Matching Has No Survival Benefit for AB Heart Transplant Recipients Henrik Bergenfeldt, MD, Peter Höglund, MD, PhD, Bodil Andersson,

Burdens Without Blessings: Peer Reviewers Get No Respect

Less Is More in Post Pediatric Heart Transplant Care

Operative Results and Outcomes in Children With Shone's Anomaly

Emanuela Taioli, MD, PhD, Andrea S

Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication? Nishant D. Patel, BA, Jason.

FDA Perspective on Clinical Trial Design for Cardiovascular Devices

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD

Demographic, Psychosocial, and Behavioral Factors Associated With Survival After Heart Transplantation Steven A. Farmer, MD, PhD, Kathleen L. Grady,

Robotic Thymectomy in Anterior Mediastinal Mass: Propensity Score Matching Study With Transsternal Thymectomy Chang Hyun Kang, MD, PhD, Yoohwa Hwang,

Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C

Who Do You Say You Are? The Annals of Thoracic Surgery

Ventricular assist device programs: design and function

Saving Lives Is More Important Than Abstract Moral Concerns: Financial Incentives Should Be Used to Increase Organ Donation Benjamin Hippen, MD, Lainie.

Use of Amiodarone After Major Lung Resection

Jaimin R. Trivedi, MD, MPH, Allen Cheng, MD, Michele Gallo, MD, Erin M

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman.

Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9- Year Experience Jeffrey A. Morgan, MD, Pauline H. Go, MD, Linnea.

Nicholas A. Haglund, MD, Mary E. Davis, MS, CCRP, Nicole M

Low-Dose Prophylactic Intravenous Immunoglobulin Does Not Prevent HLA Sensitization in Left Ventricular Assist Device Recipients Stavros G. Drakos, MD,

Determinants of Left Ventricular Dysfunction After Repair of Chronic Asymptomatic Mitral Regurgitation Vincent Chan, MD, MPH, Marc Ruel, MD, MPH, Elsayed.

Colonization With Multiresistant Bacteria: Impact on Ventricular Assist Device Patients Maria Papathanasiou, MD, Julia Pohl, MD, Rolf Alexander Jánosi,

Arman Kilic, MD, Eric S. Weiss, MD, MPH, Jeremiah G

John F. Lazar, MD, Michael F. Swartz, PhD, Matthew P

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

Michael J. Wolf, MD, Kirk R. Kanter, MD, Paul M. Kirshbom, MD, Brian E

Dhaval Chauhan, MD, Alexis K

Editorial Board, January 2010

Bradford B. Smith, MD, Matthew A

William M. Whited, MD, Paul Henley, BS, Erin M

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

Mechanical Circulatory Support and Heart Transplantation: Donor and Recipient Factors Influencing Graft Survival Simon Maltais, MD, PhD, Nikhil P. Jaik,

An Unusual Cause of Hemoptysis in a Young Woman

Deterioration of a Tricuspid Bioprosthesis Due to Adhesion of the Native Valve Herbert Gutermann, MD, Willem Flameng, MD, PhD, Paul Herijgers, MD, PhD

Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure Erin M. Schumer,

Single Versus Double Lung Retransplantation Does Not Affect Survival Based on Previous Transplant Type Erin M. Schumer, MD, MPH, Jonathan D. Rice, MD,

Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant.

Invited Commentary The Annals of Thoracic Surgery

Robert Lee Replogle, September 30, 1931–May 9, 2016

Digital Drainage System Reduces Hospitalization After Video-Assisted Thoracoscopic Surgery Lung Resection Daniel L. Miller, MD, Gerald A. Helms, MD,

The Impact of Volume Reduction on Early and Long-Term Outcomes in Surgical Ventricular Restoration for Severe Heart Failure Nathan Wm. Skelley, BS, Jeremiah.

Pulmonary Embolectomy for Acute Massive Pulmonary Embolism

The American Board of Thoracic Surgery: Update

Farhan Zafar, MD, John L. Jefferies, MD, MPH, Christine J

“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:

Late Aortic Insufficiency Related to Poor Prognosis During Left Ventricular Assist Device Support Koichi Toda, MD, PhD, Tomoyuki Fujita, MD, Keitaro.

Infectious Complications in Patients With Left Ventricular Assist Device: Etiology and Outcomes in the Continuous-Flow Era Veli K. Topkara, MD, Sreekanth.

Y. Joseph Woo, MD, Michael A. Acker, MD The Annals of Thoracic Surgery

Use of Ventricular Assist Devices in Children Across the United States: Analysis of 7.5 Million Pediatric Hospitalizations David L.S. Morales, MD, Farhan.

Costs Associated With Ventricular Assist Device Use in Children

Late Consequences of a Much Earlier Decision

The Impact of New Technology on Cardiothoracic Surgical Practice

Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation Marat Fudim, MD, Mary E. Davis, MS,

Heart Transplant Program Volume Is Not a Measure of Quality

Significance of Postoperative Acute Renal Failure After Continuous-Flow Left Ventricular Assist Device Implantation Jamil Borgi, MD, Athanasios Tsiouris,

Repair of Left Ventricular Inflow Tract Lesions in Shone's Anomaly: Valve Growth and Long-Term Outcome Eva Maria B. Delmo Walter, MD, PhD, Richard Van.

Presentation transcript:

Does Donor Cardiopulmonary Resuscitation Time Affect Heart Transplantation Outcomes and Survival? Allen Cheng, MD, Erin M. Schumer, MD, MPH, Jaimin R. Trivedi, MD, MPH, Victor H. Van Berkel, MD, PhD, H. Todd Massey, MD, Mark S. Slaughter, MD The Annals of Thoracic Surgery Volume 102, Issue 3, Pages 751-758 (September 2016) DOI: 10.1016/j.athoracsur.2016.02.034 Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Survival after heart transplant of recipients of donors with no cardiopulmonary resuscitation (CPR), less than 20 minutes of CPR, 20 to 30 minutes of CPR, and greater than 30 minutes of CPR. The Annals of Thoracic Surgery 2016 102, 751-758DOI: (10.1016/j.athoracsur.2016.02.034) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Posttransplant recipient survival with donor with no cardiopulmonary resuscitation (CPR), less than 20 minutes of CPR, 20 to 30 minutes of CPR, and greater than 30 minutes of CPR (p = 0.5) in recipients with (+) or without (–) left ventricular assist device (LVAD) support. The Annals of Thoracic Surgery 2016 102, 751-758DOI: (10.1016/j.athoracsur.2016.02.034) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Percentage of transplants using donors who underwent cardiopulmonary resuscitation (CPR) during 2005 to 2013 in the United States (US). The Annals of Thoracic Surgery 2016 102, 751-758DOI: (10.1016/j.athoracsur.2016.02.034) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Propensity-matched posttransplant survival between groups with cardiopulmonary resuscitation (w/CPR) and without CPR (w/o CPR; p = 0.2). The Annals of Thoracic Surgery 2016 102, 751-758DOI: (10.1016/j.athoracsur.2016.02.034) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions